Elanco Animal Health (ELAN) Other Working Capital Changes (2018 - 2026)
Elanco Animal Health (ELAN) reported Other Working Capital Changes of $21.0 million for Q1 2026, up 310.0% on a YoY basis from $5.1 million in Q1 2025, and down 59.62% sequentially from $52.0 million in Q4 2025.
Elanco Animal Health (ELAN) Other Working Capital Changes (2018 - 2026) Analysis & Trends
Elanco Animal Health (ELAN) has 10 years of Other Working Capital Changes data on file, last reported at $21.0 million in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 310.0% year-over-year to $21.0 million; the trailing twelve-month figure through Mar 2026 stood at $25.0 million (up 8.7% YoY), and the FY2025 full-year result was -$6.0 million, down 300.0% from the prior year.
- Other Working Capital Changes retreated to $21.0 million in Q1 2026, from $52.0 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $439.0 million in Q1 2023 to a low of -$440.0 million in Q4 2023.
- A 5-year average of $20.4 million and a median of $1.0 million in 2022 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes surged 1050.0% in 2023 and plunged 600.0% in 2024, its largest moves.
- Tracing ELAN's Other Working Capital Changes over 5 years: stood at -$2.0 million in 2022, then surged by 1050.0% to $19.0 million in 2023, then surged by 173.68% to $52.0 million in 2024, then changed by 0.0% to $52.0 million in 2025, then plunged by 59.62% to $21.0 million in 2026.
- Business Quant data shows ELAN's Other Working Capital Changes at $21.0 million in Q1 2026, $52.0 million in Q4 2025, and -$30.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 263.00 Mn |
| Mar 31, 2026 | 263.00 Mn |
| Mar 31, 2026 | 263.00 Mn |
| Dec 31, 2025 | -147.00 Mn |
| Dec 31, 2025 | -147.00 Mn |
| Dec 31, 2025 | -147.00 Mn |
| Sep 30, 2025 | -59.00 Mn |
| Sep 30, 2025 | -59.00 Mn |
| Sep 30, 2025 | -59.00 Mn |
| Jun 30, 2025 | -52.00 Mn |
| Jun 30, 2025 | -52.00 Mn |
| Jun 30, 2025 | -52.00 Mn |
| Mar 31, 2025 | 237.00 Mn |
| Mar 31, 2025 | 237.00 Mn |
| Mar 31, 2025 | 237.00 Mn |
| Dec 31, 2024 | 82.00 Mn |
| Dec 31, 2024 | 82.00 Mn |
| Dec 31, 2024 | 82.00 Mn |
| Sep 30, 2024 | -248.00 Mn |
| Sep 30, 2024 | -248.00 Mn |